Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome (Q44854853)

6 December 2017

Effects of a novel dual lipid synthesis inhibitor and its potential utility in treating dyslipidemia and metabolic syndrome (English)

1 reference

6 December 2017

1 reference

1 reference

Clay T Cramer

1

1 reference

6 December 2017

Brian Goetz

2

1 reference

6 December 2017

Krista L M Hopson

3

1 reference

6 December 2017

Gregory J Fici

4

1 reference

6 December 2017

Rose M Ackermann

5

1 reference

6 December 2017

Stephen C Brown

6

1 reference

6 December 2017

Charles L Bisgaier

7

1 reference

6 December 2017

W G Rajeswaran

8

1 reference

6 December 2017

Daniela C Oniciu

9

1 reference

6 December 2017

Michael E Pape

10

1 reference

6 December 2017

language of work or name

1 reference

21 April 2004

1 reference

Journal of Lipid Research

6 December 2017

1 reference

6 December 2017

45

1 reference

6 December 2017

7

1 reference

6 December 2017

1289-1301

1 reference

5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids

6 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by beta, beta'-tetramethylhexadecanedioic acid (MEDICA 16).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Metabolic effects of thia fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

The biochemistry of hypo- and hyperlipidemic fatty acid derivatives: metabolism and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Suppression of hepatocyte nuclear factor-4alpha by acyl-CoA thioesters of hypolipidemic peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Tissue selective modulation of redox and phosphate potentials by beta,beta'-methyl-substituted hexadecanedioic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Inhibition of rat liver acetyl-CoA carboxylase by beta, beta'-tetramethyl-substituted hexadecanedioic acid (MEDICA 16).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Isolation and culture of hepatocytes from the cynomolgus monkey (Macaca fascicularis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Metabolic consequences of fasting in old lean and obese Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Regulation of mammalian acetyl-coenzyme A carboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Interaction of malonyl-CoA and related compounds with mitochondria from different rat tissues. Relationship between ligand binding and inhibition of carnitine palmitoyltransferase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Carnitine acyltransferase activities in rat liver and heart measured with palmitoyl-CoA and octanoyl-CoA. Latency, effects of K+, bivalent metal ions and malonyl-CoA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Purification and characterization of the AMP-activated protein kinase. Copurification of acetyl-CoA carboxylase kinase and 3-hydroxy-3-methylglutaryl-CoA reductase kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Physiological regulation of acetyl-CoA carboxylase gene expression: effects of diet, diabetes, and lactation on acetyl-CoA carboxylase mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Anti-hyperlipidemic action of a newly synthesized benzoic acid derivative, S-2E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Comparative effects of (−)-hydroxycitrate and (+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Reciprocal effects of 5-(tetradecyloxy)-2-furoic acid on fatty acid oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

Activation of alkylthioacrylic acids in subcellular fractions of rat tissues: a new spectrophotometric method for assay of acyl-CoA synthetase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

De novo lipogenesis in humans: metabolic and regulatory aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400018-JLR200

10.1194/JLR.M400018-JLR200

21 January 2018

Identifiers

DOI

1 reference

release_pwtf4kvl5zdr7bvd7s4hsedg74

6 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pwtf4kvl5zdr7bvd7s4hsedg74

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference